Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 22, 2024JAAD InternationalOpen Access

Biologic anti-IL17 drugs in erythrodermic psoriasis

View Full Paper
Ask AI
Bookmark
Share

Authors

AFAlessandro FalcoCMCristina MughedduJAJasmine Anedda

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Falco et al. (2024) studied this question.

synapsesocial.com/papers/68e63af7b6db6435875cd05chttps://doi.org/10.1016/j.jdin.2024.05.007
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Management of Erythrodermic Psoriasis with Systemic Therapies: A Systematic Review2025 · 4 citations
  2. 2Systemic Treatment and Outcome in Erythrodermic Psoriasis: A Retrospective Multicenter Study2026
  3. 3Advancing Therapeutic Horizons in Erythrodermic Psoriasis: A Comprehensive Review of Pathophysiology, Biomarkers, and Novel Treatments2025
  4. 4Systemic Treatment and Outcome in Erythrodermic Psoriasis: A Retrospective Multicenter Study2026
  5. 5Advantages of IL-17 inhibitor, ixekizumab, in the treatment of severe psoriasis2024